QC
MRNA icon

QCM Cayman’s Moderna MRNA Stock Holding History

QCM Cayman’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,244
Closed -$214K – 73
2022
Q1 		$214K Buy
1,244
+451
+57% +$75.9K 0.94% 57
2021
Q4 		$201K Buy
+793
New +$232K 1.22% 47
2021
Q3 		– Sell
-880
Closed -$207K – 149
2021
Q2 		$207K Buy
+880
New +$157K 0.54% 85
2021
Q1 		– Sell
-3,534
Closed -$369K – 215
2020
Q4 		$369K Buy
+3,534
New +$358K 0.38% 80
2020
Q3 		– Sell
-3,187
Closed -$205K – 201
2020
Q2 		$205K Buy
+3,187
New +$175K 0.47% 103

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

QCM Cayman's MRNA Position: Q2 2022 in Review

QCM Cayman sold out of Moderna (MRNA) in Q2 2022, closing a stake of 1,244 shares — an estimated $214K sold.

QCM Cayman first reported a position in MRNA in Q2 2020 and held it in 5 quarters. The position peaked at $369K in Q4 2020. 981 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.

  • QCM Cayman reported no remaining Moderna position as of Q2 2022 after selling out during the quarter.
  • QCM Cayman sold 1,244 Moderna shares in Q2 2022, an estimated $214K.
  • QCM Cayman first reported a position in Moderna in Q2 2020 and held it in 5 quarters.
  • QCM Cayman's Moderna position peaked at $369K in Q4 2020.
  • 981 funds tracked by Wall St. Rank held Moderna as of Q2 2022.

Based on QCM Cayman's 13F filing for Q2 2022, filed 27 Jul 2022.